Current position:Home >Product >
N-[(20S)-20-(Dimethylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregnan-3β-yl]-N-methylacetamide
N-[(20S)-20-(Dimethylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregnan-3β-yl]-N-methylacetamide(16975-11-4)
- Name: N-[(20S)-20-(Dimethylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregnan-3β-yl]-N-methylacetamide
- Synonyms:Acetamide,N-[20a-(dimethylamino)-4,4,14-trimethyl-9,19-cyclo-5a,9b-pregnan-3b-yl]-N-methyl- (8CI); 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene,acetamide deriv.; 9,19-Cyclopregnane, acetamide deriv.; Buxaline C;N-Acetylcycloprotobuxine C
- Molecular Formula:C29H50 N2 O
- Molecular Weight:442.729
- CAS Registry Number:16975-11-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.16975-11-4 N-[(20S)-20-(dimethylamino)-4,4,14-trimethyl-9,19-cyclo-5伪-pregnan-3尾-yl]-N-methylacetamide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 75673-30-2/methyl [1-(ethylcarbamoyl)-1H-benzimidazol-2-yl]carbamate
- 5414-55-1/4-[(4-{[4-(2,5-dimethyl-1H-pyrrol-1-yl)phenyl]sulfonyl}phenyl)amino]-4-oxobutanoic acid
- 3984-14-3/N,N-Dimethylsulfamide
- 68073-22-3/CRYPTOESCIN
- 60548-82-5/Natalenone
- 35081-10-8/N-(4-{(E)-[4-(acetylamino)phenyl]diazenyl}phenyl)-N-methylacetamide
- 7610-45-9/Methyl trioxodibromoantimonate(V) ((MeO)3SbBr2)
- 6269-68-7/N-(4-amino-2-methylquinolin-6-yl)benzamide
- 16816-28-7/methyl N-[(benzyloxy)carbonyl]glycylalaninate
- 93164-85-3/Amines, C20-22-alkyldimethyl
- 15500-74-0/Benzonitrile,4-chloro-N-oxide
- 207502-74-7/Isocalanone
- 39964-49-3/[(2Z)-2-(cyclopentylimino)-3-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-5-yl]acetic acid
- 100209-44-7/Protein hydrolyzates,sunflower
- 57734-47-1/5-(aminosulphonyl)-2,3-dimethoxybenzoyl chloride
- 66223-15-2/3-methyl-8-[(4-methylpiperazin-1-yl)methyl]-2,7-dioxaspiro[4.4]nonane-1,6-dione
- 69173-79-1/4-nitro-N-[(E)-phenylmethylidene]aniline
- 85187-85-5/[4-[(2-chlorophenyl)(1-methyl-2-phenyl-1H-indol-3-yl)methylene]-2,5-cyclohexadien-1-ylidene]diethyl methyl sulphate
- 7478-75-3/4-[1-(4-dimethylaminophenyl)but-1-enyl]-N,N-dimethyl-aniline; 2,4,6-trinitrophenol
- 16975-11-4/N-[(20S)-20-(Dimethylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregnan-3β-yl]-N-methylacetamide
- 96548-01-5/1,3,4-Oxadiazole-2(3H)-thione, 5-(((2-methyl-4-quinazolinyl)oxy)methyl)-3-(1-piperidinylmethyl)-
- 90181-99-0/2-hydroxy-4-oxo-3-(phenylcarbonyl)-1,4-dihydroquinoline-6-carboxylic acid
- 73484-89-6/Thiacyclohexadecan-2-one
- 55364-14-2/Phosphatriptycene
- 87860-39-7/FOSTRIECIN SODIUM SALT
- 20987-59-1/cholecystokinin (27-33), t-butyloxycarbonyl-
- 6950-19-2/6-[(2,4-dichlorobenzyl)sulfanyl]-5H-purin-2-amine
- 850429-59-3/4-BROMO-1,2-DIMETHYL-1H-IMIDAZOLE
- 19341-47-0/N,N-dicyclohexyl-3,9-dioxo-2,4,8,10-tetraoxa-3$l^C17H32N2O6P2,9$l^C17H32N2O6P2-diphosphaspiro[5.5]undecane-3,9-diamine
- 170516-41-3/Glycine,N-[2-(carboxymethoxy)-4-[[(2',7'-dichloro-3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)carbonyl]amino]phenyl]-N-(carboxymethyl)-,potassium salt (1:5)